SubsidieMeestersLive Cell Spectroscopy Analysis for Personalised Particle Radiation Therapy of Metastatic Bone Cancer
BoneOscopy aims to revolutionize metastatic bone cancer treatment by enabling daily monitoring during particle radiotherapy, enhancing personalized care and treatment efficacy.
Projectdetails
Introduction
Metastatic bone cancer is an incurable disease and one of the most complex cancers to treat. Due to the high dose, tumour imaging is currently performed at the beginning and end of standard particle radio-therapy (PRT), making personalised treatment difficult.
Project Goal
The main goal of BoneOscopy is to develop a radically new technology to enable informed medical decisions by monitoring bone cancer on a daily basis during PRT. At the heart of BoneOscopy is the ability to detect prompt gamma (PGs) emitted by cancer during PRT and separate them from healthy tissue, unlocking the full potential of spectroscopic analysis without the need for additional dose.
Technology Development
The development of a highly specialised detection and collimation system will enable accurate spectroscopic analysis of a very small volume or region within the cancer. As the number of PRT centres grows, we anticipate that within 10 years BoneOscopy will benefit all patients treated with proton and carbon ions.
Consortium
The objectives of BoneOscopy will be achieved by its interdisciplinary consortium, which brings together six partners from five European countries with key expertise in:
- Bioengineering and PRT (DKFZ)
- Medical physics and engineering (CSIC)
- Fast electronics for PRT (LIP)
- Monte Carlo simulations and clinical PRT experience (THM)
- Turnkey software for high-performance medical devices (Cosylab)
- EU project management, communication, and dissemination (accelCH)
Impact
If achieved, the proposed science-to-technology breakthrough will have a transformative impact on current cancer treatment by providing a safe, personalised, and quantitative measure of daily treatment efficacy, thereby contributing to the global fight against cancer.
Summary
In summary, BoneOscopy will lead to a significant reduction in the health burden in Europe and worldwide, improved quality of life for patients, reduced costs for healthcare systems, and improved sustainability of healthcare.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 3.069.321 |
| Totale projectbegroting | € 3.069.321 |
Tijdlijn
| Startdatum | 1-1-2025 |
| Einddatum | 31-12-2029 |
| Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERGpenvoerder
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
- LABORATORIO DE INSTRUMENTACAO E FISICA EXPERIMENTAL DE PARTICULAS LIP
- COSYLAB LABORATORIJ ZA KONTROLNE SISTEME DD
- TECHNISCHE HOCHSCHULE MITTELHESSEN
- ACCELOPMENT SCHWEIZ AG
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.NuCapCure aims to develop novel cancer treatments for glioblastoma by utilizing custom-made drugs through biosynthesis to enhance proton and neutron therapies for better targeting and efficacy. | EIC Pathfinder | € 5.972.875 | 2024 | Details |
2D Material-Based Multiple Oncotherapy Against Metastatic Disease Using a Radically New Computed Tomography ApproachPERSEUS aims to develop a novel nanotechnology-based cancer therapy that activates under CT imaging to treat deep-seated, drug-resistant tumors with minimal side effects. | EIC Pathfinder | € 2.740.675 | 2023 | Details |
Bone Marrow-on-Chip as smart sensor of lung cancer relapseBuonMarrow aims to develop an innovative in vitro device using bone marrow mesenchymal stromal cells to early detect lung cancer relapse, enhancing personalized treatment and patient survival. | EIC Pathfinder | € 2.999.835 | 2024 | Details |
MULTIMODE NONLINEAR FIBER BASED ENDOSCOPIC IMAGING AND TREATMENTMULTISCOPE aims to revolutionize optical diagnostics and therapy by developing a dual-function endoscopic device for real-time optical biopsy and cold atmospheric plasma treatment in gastrointestinal care. | EIC Pathfinder | € 2.863.733 | 2024 | Details |
Next generation Limited-Angle time-of-flight PET imagerThe PetVision project aims to develop a cost-effective, modular PET imaging device with enhanced sensitivity to improve cancer diagnostics accessibility across various medical settings. | EIC Pathfinder | € 3.374.041 | 2023 | Details |
Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.
NuCapCure aims to develop novel cancer treatments for glioblastoma by utilizing custom-made drugs through biosynthesis to enhance proton and neutron therapies for better targeting and efficacy.
2D Material-Based Multiple Oncotherapy Against Metastatic Disease Using a Radically New Computed Tomography Approach
PERSEUS aims to develop a novel nanotechnology-based cancer therapy that activates under CT imaging to treat deep-seated, drug-resistant tumors with minimal side effects.
Bone Marrow-on-Chip as smart sensor of lung cancer relapse
BuonMarrow aims to develop an innovative in vitro device using bone marrow mesenchymal stromal cells to early detect lung cancer relapse, enhancing personalized treatment and patient survival.
MULTIMODE NONLINEAR FIBER BASED ENDOSCOPIC IMAGING AND TREATMENT
MULTISCOPE aims to revolutionize optical diagnostics and therapy by developing a dual-function endoscopic device for real-time optical biopsy and cold atmospheric plasma treatment in gastrointestinal care.
Next generation Limited-Angle time-of-flight PET imager
The PetVision project aims to develop a cost-effective, modular PET imaging device with enhanced sensitivity to improve cancer diagnostics accessibility across various medical settings.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Transforming bone cancer therapy with composite biomaterials encapsulating plasma-generated RONSTRANSFORMER aims to develop a novel therapy combining cold atmospheric plasma-treated hydrogels with biomaterials for simultaneous osteosarcoma treatment and bone regeneration, enhancing patient outcomes. | ERC Proof of... | € 150.000 | 2022 | Details |
Treatment planning assessment for the Optiflux radiosurgery systemDit project ontwikkelt een innovatieve radiotherapie met sub-MeV X-stralen voor nauwkeurige tumorbehandeling en minder schade aan omliggende organen. | Mkb-innovati... | € 20.000 | 2021 | Details |
Radically New Cancer Therapy Based on Advances in Nanotechnology and Photonics for Simultaneous Imaging and Treatment of Solid TumoursScanNanoTreat aims to revolutionize cancer treatment by integrating advanced imaging and therapy technologies to improve patient outcomes and reduce costs, targeting clinical trials by 2027. | EIC Transition | € 2.499.911 | 2025 | Details |
Prompt Gamma Time Imaging: a new medical-imaging modality for adaptive Particle TherapyThe project aims to enhance particle therapy efficacy and safety by developing Prompt Gamma Time Imaging for real-time monitoring of treatment, improving dose control and adaptive dosimetry. | ERC Starting... | € 1.498.969 | 2022 | Details |
A Health Technology Assessment of a breakthrough technology in the early diagnosis of Osteoporosis and other bone related diseases.The Porous solution aims to revolutionize osteoporosis diagnosis by using mobile ultrasound technology to assess cortical bone quality and fracture risk more effectively than current BMD methods. | EIC Accelerator | € 2.500.000 | 2023 | Details |
Transforming bone cancer therapy with composite biomaterials encapsulating plasma-generated RONS
TRANSFORMER aims to develop a novel therapy combining cold atmospheric plasma-treated hydrogels with biomaterials for simultaneous osteosarcoma treatment and bone regeneration, enhancing patient outcomes.
Treatment planning assessment for the Optiflux radiosurgery system
Dit project ontwikkelt een innovatieve radiotherapie met sub-MeV X-stralen voor nauwkeurige tumorbehandeling en minder schade aan omliggende organen.
Radically New Cancer Therapy Based on Advances in Nanotechnology and Photonics for Simultaneous Imaging and Treatment of Solid Tumours
ScanNanoTreat aims to revolutionize cancer treatment by integrating advanced imaging and therapy technologies to improve patient outcomes and reduce costs, targeting clinical trials by 2027.
Prompt Gamma Time Imaging: a new medical-imaging modality for adaptive Particle Therapy
The project aims to enhance particle therapy efficacy and safety by developing Prompt Gamma Time Imaging for real-time monitoring of treatment, improving dose control and adaptive dosimetry.
A Health Technology Assessment of a breakthrough technology in the early diagnosis of Osteoporosis and other bone related diseases.
The Porous solution aims to revolutionize osteoporosis diagnosis by using mobile ultrasound technology to assess cortical bone quality and fracture risk more effectively than current BMD methods.